Download video

Pirtobrutinib shows efficacy in BTKi refractory Waldenström’s macroglobulinemia patients

143 views

VJHemOnc – Video Journal of Hematology & HemOnc

2 years ago

Pirtobrutinib shows efficacy in BTKi refractory Waldenström’s macroglobulinemia patients

Pirtobrutinib shows efficacy in BTKi refractory Waldenström’s macroglobulinemia patients

BRUIN study cohort update: pirtobrutinib for patients with MCL
1:18
BRUIN study cohort update: pirtobrutinib for patients with MCL
by VJHemOnc – Video Journal of Hematology \& HemOnc
Pirtobrutinib for BTK inhibitor-naïve and BTK inhibitor pre-treated R\/R MCL
2:12
Pirtobrutinib for BTK inhibitor-naïve and BTK inhibitor pre-treated R\/R MCL
by VJHemOnc – Video Journal of Hematology \& HemOnc
Safety and efficacy of pirtobrutinib in patients with covalent BTKi-intolerant B-cell malignancies
1:19
Safety and efficacy of pirtobrutinib in patients with covalent BTKi-intolerant B-cell malignancies
by VJHemOnc – Video Journal of Hematology \& HemOnc
The current and future role of pirtobrutinib in the management of CLL
1:16
The current and future role of pirtobrutinib in the management of CLL
by VJHemOnc – Video Journal of Hematology \& HemOnc
Glofitamab \& Pirtobrutinib for Relapsed\/Refractory Mantle Cell Lymphoma -Blood Cancers Video Library
3:52
Glofitamab \& Pirtobrutinib for Relapsed\/Refractory Mantle Cell Lymphoma -Blood Cancers Video Library
by Global Resource for Advancing Cancer Education
Pirtobrutinib: The next generation of BTK inhibitors
1:18
Pirtobrutinib: The next generation of BTK inhibitors
by VJHemOnc – Video Journal of Hematology \& HemOnc
Phase I\/II BRUIN study: pirtobrutinib in patients intolerant to a covalent BTK inhibitor
1:08
Phase I\/II BRUIN study: pirtobrutinib in patients intolerant to a covalent BTK inhibitor
by VJHemOnc – Video Journal of Hematology \& HemOnc
Pirtobrutinib versus covalent BTKis and advice for managing toxicities
1:32
Pirtobrutinib versus covalent BTKis and advice for managing toxicities
by VJHemOnc – Video Journal of Hematology \& HemOnc
The BRUIN CLL-321 trial: a Phase III trial of pirtobrutinib in covalent BTKi-exposed CLL\/SLL
2:44
The BRUIN CLL-321 trial: a Phase III trial of pirtobrutinib in covalent BTKi-exposed CLL\/SLL
by VJHemOnc – Video Journal of Hematology \& HemOnc
DVT\/PE Despite Anticoagulation: Lets Bleep Haematology
5:15
DVT\/PE Despite Anticoagulation: Lets Bleep Haematology
by Haematology, Morphology, FRCPath Exams
Paraprotein\/Myeloma Screen-Let's Bleep Haematology😃
12:40
Paraprotein\/Myeloma Screen-Let's Bleep Haematology😃
by Haematology, Morphology, FRCPath Exams
Efficacy and Safety of Acalabrutinib Vs. Zanubrutinib for CLL (Chronic Lymphocytic Leukemia)
6:35
Efficacy and Safety of Acalabrutinib Vs. Zanubrutinib for CLL (Chronic Lymphocytic Leukemia)
by CLL Society
Pirtobrutinib Non-Covalent BTK Inhibitor for Chronic Lymphocytic Leukemia (CLL) - BRUIN Study
8:55
Pirtobrutinib Non-Covalent BTK Inhibitor for Chronic Lymphocytic Leukemia (CLL) - BRUIN Study
by CLL Society
The current role of pirtobrutinib in CLL \& looking beyond BTKis for patients who develop resistance
2:03
The current role of pirtobrutinib in CLL \& looking beyond BTKis for patients who develop resistance
by VJHemOnc – Video Journal of Hematology \& HemOnc
Updated results of Phase I\/II BRUIN study: pirtobrutinib in covalent BTK inhibitor pretreated MCL
1:56
Updated results of Phase I\/II BRUIN study: pirtobrutinib in covalent BTK inhibitor pretreated MCL
by VJHemOnc – Video Journal of Hematology \& HemOnc
The pharmacokinetics of pirtobrutinib
1:57
The pharmacokinetics of pirtobrutinib
by VJHemOnc – Video Journal of Hematology \& HemOnc
Phase I\/II BRUIN update: efficacy of pirtobrutinib in R\/R Waldenström's macroglobulinemia
1:35
Phase I\/II BRUIN update: efficacy of pirtobrutinib in R\/R Waldenström's macroglobulinemia
by VJHemOnc – Video Journal of Hematology \& HemOnc
Pirtobrutinib in CLL: updates from the BRUIN CLL-321 trial
1:08
Pirtobrutinib in CLL: updates from the BRUIN CLL-321 trial
by VJHemOnc – Video Journal of Hematology \& HemOnc
BRUIN MCL-321: pirtobrutinib vs investigator choice of BTK inhibitor in BTK inhibitor-naive MCL
1:10
BRUIN MCL-321: pirtobrutinib vs investigator choice of BTK inhibitor in BTK inhibitor-naive MCL
by VJHemOnc – Video Journal of Hematology \& HemOnc
BRUIN CLL-322: pirtobrutinib plus VR vs VR alone in R\/R CLL
0:50
BRUIN CLL-322: pirtobrutinib plus VR vs VR alone in R\/R CLL
by VJHemOnc – Video Journal of Hematology \& HemOnc
Genomic evolution \& resistance to pirtobrutinib in covalent BTK inhibitor pre-treated CLL
1:32
Genomic evolution \& resistance to pirtobrutinib in covalent BTK inhibitor pre-treated CLL
by VJHemOnc – Video Journal of Hematology \& HemOnc
The use of pirtobrutinib after a covalent BTKi in pretreated CLL
2:06
The use of pirtobrutinib after a covalent BTKi in pretreated CLL
by VJHemOnc – Video Journal of Hematology \& HemOnc
Updated results from the BRUIN study: pirtobrutinib in the treatment of MCL
1:59
Updated results from the BRUIN study: pirtobrutinib in the treatment of MCL
by VJHemOnc – Video Journal of Hematology \& HemOnc